Klarskov P, Lund F, Petersen S E
Department of Urology, Herlev Hospital, Denmark.
Int Urol Nephrol. 1990;22(4):359-62. doi: 10.1007/BF02549796.
Twelve patients with advanced prostatic carcinoma and relapse following previous hormone manipulation therapy were treated with Zoladex-depot every 4 weeks. The treatment was well tolerated and the endocrine response was satisfactory. However, no clinically important improvement was obtained.
12例晚期前列腺癌患者，在先前接受激素治疗后复发，每4周接受一次长效醋酸戈舍瑞林治疗。治疗耐受性良好，内分泌反应令人满意。然而，未获得临床上重要的改善。
